Weider Margareta, Schlagenhauf Ulrich, Seefried Lothar
Division of Periodontology, University Hospital Wuerzburg, Wuerzburg, Germany.
Clinical Trial Unit, Orthopedic Department, University of Wuerzburg, Wuerzburg, Germany.
J Clin Periodontol. 2022 Dec;49(12):1253-1261. doi: 10.1111/jcpe.13718. Epub 2022 Sep 7.
This study evaluated the oral health status of adult patients with hypophosphatasia (HPP).
Parameters of oral health assessment comprised decayed/missing/filled teeth (DMFT) index, probing pocket depth and clinical attachment level (CAL) as well as documentation of tooth loss and periodontal health status according to CCD/AAP criteria. Findings were compared with national reference data (DMS V survey) reporting oral health status in age-related controls. Within-group comparisons were made between the HPP patients harbouring one versus two alkaline phosphatase liver/bone/kidney type (ALPL) gene variants.
Of 80 HPP patients (64 female) with a mean age of 46.4 years (range 24-78) and one (n = 55) or two (n = 18) variants (n = 7 lacking testing) within the ALPL gene, those with two variants displayed substantially higher tooth loss rate (14.0 ± 9.3) than those affected by only one ALPL variant (4.1 ± 5.4), who did not differ substantially from healthy DMS V controls. While DMFT score and severe periodontal diseases (PDs) of HPP patients with one variant only increased with progressing age, the two-variant sub-cohort age independently exhibited increased DMFT scores and a higher rate of severe PDs.
HPP patients affected by two variants of the ALPL gene exhibited a higher risk of periodontitis and tooth loss than the general population, while patients with one variant developed clinically relevant oral disease symptoms with progressing ageing.
gov identifier: NCT02291497.
本研究评估了低磷酸酯酶症(HPP)成年患者的口腔健康状况。
口腔健康评估参数包括龋失补牙(DMFT)指数、探诊深度和临床附着水平(CAL),以及根据CCD/AAP标准记录的牙齿缺失情况和牙周健康状况。将研究结果与报告年龄相关对照人群口腔健康状况的国家参考数据(DMS V调查)进行比较。在携带一个与两个碱性磷酸酶肝/骨/肾型(ALPL)基因变异的HPP患者之间进行组内比较。
在80例平均年龄为46.4岁(范围24 - 78岁)的HPP患者(64例女性)中,ALPL基因存在一个(n = 55)或两个(n = 18)变异(n = 7例未进行检测),携带两个变异的患者牙齿缺失率(14.0 ± 9.3)显著高于仅携带一个ALPL变异的患者(4.1 ± 5.4),后者与健康的DMS V对照人群无显著差异。仅携带一个变异的HPP患者的DMFT评分和重度牙周病(PDs)仅随年龄增长而增加,而携带两个变异的亚组患者的DMFT评分独立增加且重度PDs发生率更高。
与普通人群相比,携带两个ALPL基因变异的HPP患者患牙周炎和牙齿缺失的风险更高,而携带一个变异的患者随着年龄增长会出现临床相关的口腔疾病症状。
gov标识符:NCT02291497。